throbber
Acta Neurol Scand 2005: 112: 259–264 DOI: 10.1111/j.1600-0404.2005.00476.x
`
`Copyright Ó Blackwell Munksgaard 2005
`ACTA NEUROLOGICA
`SCANDINAVICA
`
`Hypertension in headache patients? A
`clinical study
`
`Pietrini U, De Luca M, De Santis G. Hypertension in headache patients?
`A clinical study.
`Acta Neurol Scand 2005: 112: 259–264. Ó Blackwell Munksgaard 2005.
`
`Objectives – The aim of the present study was to assess the prevalence
`of hypertension in patients with headache, coming to the observation
`of an Headache Center. Materials and methods – A total of 1486
`consecutive outpatients were examined, and blood pressure was
`determined in all patients. Results – Migraine without aura (MO) was
`the most common diagnosis, followed by migraine associated with
`tension-type headache, migraine with aura (MA), episodic tension-type
`headache (ETTH), chronic tension-type headache (CTTH), cluster
`headache (CH), and medication-overuse headache (MOH).
`Hypertension was present in 28% of the patients, and it was
`particularly common in MOH (60.6%), CTTH (55.3%), CH (35%),
`ETTH (31.4%), less common in MO (23%) and MA (16.9%). In all
`headache groups, the prevalence of hypertension was higher than in the
`general population, within all age groups. After adjustment for age and
`gender, hypertension was found to be more common in tension-type,
`and especially in CTTH, than in migraine. These findings could be
`affected by ÔBerkson’s biasÕ: and should not be extrapolated to the
`general population, but apply only to the subpopulation of patients
`who come to the observation of an Headache Center, and who may
`have more disabling symptoms. Conclusion – Hypertension could be
`one of the factors leading to exacerbation of the frequency and severity
`of attacks, both in migraine and tension-type headache. Hypertension
`has important therapeutic implications and should be actively sought
`in headache patients, and more thoroughly investigated, with ad-hoc
`surveys in the general population.
`
`U. Pietrini1, M. De Luca1,
`G. De Santis2
`1Headache Center, Department of Internal Medicine,
`University of Florence, Florence, Italy; 2Department of
`Economics and Statistics, University of Messina,
`Messina, Italy
`
`Key words: headache; migraine; tension-type
`headache; cluster headache; medication-overuse
`headache; comorbidity; hypertension; Berkson's bias
`
`Dr Umberto Pietrini, Centro Cefalee, Dipartimento di
`medicina Interna, Villa Monna Tessa – V.le Pieraccini,
`18 – 50139 Firenze, Italy
`e-mail: u.pietrini@libero.it
`
`Accepted for publication May 20, 2005
`
`Considerable controversy surrounds the associ-
`ation of headache with hypertension, as some
`studies suggest a link with migraine and tension-
`type headache (1–3), possibly limited to high
`diastolic blood pressure and migraine in women
`(4), while other studies deny such an association
`(5–7) or, on the contrary, suggest a link between
`headache and lower values of blood pressure (8). In
`a large series of patients, however, headache was
`found to be very common in hypertensive patients,
`and to ameliorate after antihypertensive treatment
`(9). This finding has been confirmed in more recent
`
`Abbreviations: CH, cluster headache; CTTH, chronic tension-type headache; ETTH,
`episodic tension-type headache; MA, migraine with aura; MO, migraine without
`aura; MOH, medication-overuse headache.
`
`studies (10, 11). Moreover, a number of studies
`have shown an association between chronic daily
`headache and hypertension (12–16). The aim of the
`present study was to assess the prevalence of
`hypertension in outpatients with migraine, tension-
`type headache, and other forms of primary head-
`aches, or medication-overuse headache (MOH),
`coming to the observation of an Headache Center.
`
`Materials and methods
`
`Consecutive outpatients coming for their first visit
`to the ambulatory of
`the Headache Center,
`Department of Internal Medicine, University of
`Florence, from January 2000 to December 2001
`were considered for this study. At their initial visit
`all patients underwent a thorough medical visit
`
`259
`
`EX2185
`Eli Lilly & Co. v. Teva Pharms. Int'l GMBH
`IPR2018-01427
`
`1
`
`

`

`Pietrini et al.
`
`including their medical and headache history,
`general
`and
`neurological
`examination,
`and
`determination of blood pressure. In patients show-
`ing a systolic arterial blood pressure ‡140 mmHg
`or a diastolic blood pressure ‡90 mmHg two other
`blood pressure determinations in a month were
`taken for diagnosis, according to the methods
`exposed in the ÔSixth Report of the Joint National
`Committee on Prevention, Detection, Evaluation
`and Treatment of High Blood PressureÕ (17), and
`the average of the three determinations was used
`for statistical analysis.
`Patients were seated in a chair with their backs
`supported and their arms bared and supported at
`heart level. Measurements were taken after 5 min
`of rest with a mercury sphygmomanometer, and
`two readings separated by 2 min were averaged.
`The diagnosis of headache was made according to
`the IHS 1988 criteria (18), through a questionnaire
`followed by a structured interview. Eight sub-
`groups were used for the analysis: migraine with
`aura (MA), migraine without aura (MO), episodic
`tension-type headache (ETTH), chronic tension-
`Ômixed headacheÕ,
`type headache (CTTH),
`i.e.
`association of migraine with tension-type headache
`(mixed), cluster headache (CH), other forms of
`primary headaches,
`including all other
`forms
`(other), and medication-overuse headache (MOH).
`The two diagnostic classes of
`the 1988 IHS
`classification Ôergotamine-induced headacheÕ and
`Ôheadache induced by abuse of analgesicsÕ were
`merged together, and subsequently reclassified as
`MOH, according to the latest IHS classification
`(19). When more than one symptomatic drug was
`overused, the patient was classified according to
`the most frequently used drug in the last 3 months,
`based on self-reporting by patients.
`Patients with secondary headaches other than
`due to substance abuse were excluded from the
`study. Hypertension was defined as systolic blood
`pressure of 140 mmHg or higher, or diastolic
`blood pressure of 90 mmHg or higher, or current
`treatment with antihypertensive drugs. In order to
`test for the excessive prevalence of hypertension in
`(some of) the eight subgroups, we compared the
`actual to the theoretical frequencies of hypertensive
`patients in each of them. Theoretical frequencies
`were obtained with an indirect standardization, so
`as to keep into account the peculiar age and gender
`composition of each subgroup, and under the
`so-called ÔnullÕ hypothesis, i.e. assuming absence of
`influence of each diagnosis on the chances of being
`hypertensive (see the Appendix for the details). The
`significancy of the differences (actual vs theoret-
`ical) was determined using a chi-square test. As this
`proved significant (see below) for the eight-column
`
`260
`
`table, we further investigated specifically whether
`the association with hypertension differed between
`migraine (MA + MO) and tension-type headache
`(ETTH + CTTH), and as the answer was positive,
`we also compared MA to MO, and, separately,
`ETTH to CTTH, in all cases standardizing by age
`and gender, in order to obtain unbiased theoretical
`frequencies. The other headache subgroups were
`not considered in this restricted analysis, as in the
`mixed headache group migraine and tension-type
`headache coexisted, while the other groups inclu-
`ded too few patients.
`
`Results
`
`During the study period, 1486 patients (1008
`females and 478 males) were diagnosed with pri-
`mary headaches or MOH: MO was by far the most
`common diagnosis (718 patients),
`followed by
`Ômixed headacheÕ (342 patients), MA (124 patients),
`ETTH (105 patients), CTTH (94 patients), CH (60
`patients), and MOH (33 patients), while 10 patients
`presented rare forms of primary headaches. In all
`headache subgroups, women were more represented
`than men, with the exception of CH (m/f ratio ¼
`3.62) and ETTH (m/f ratio ¼ 1.1). In the MOH
`group, 28 of 33 patients overused non-steroidal anti-
`inflammatory agents (NSAIDs),
`three patients
`paracetamol, and two patients ergotamine (data
`not shown). Table 1 shows the frequency of the
`different headache subtypes in men and women.
`Hypertension was a common finding, as it was
`present in 28% of the patients, and it was partic-
`ularly common in MOH (60.6%),
`in CTTH
`(55.3%), CH (35%) and ETTH (31.4%), and less
`common in MO (22.9%) and in MA (16.9%). As
`could be expected, patients with Ômixed headacheÕ
`showed a frequency of hypertension intermediate
`between tension-type headache patients
`and
`migraine patients (Table 2).
`After adjustment for gender and age, the differ-
`ence in the prevalence of hypertension between the
`eight subgroups was less striking (Table 2, theor-
`etical prevalence), mainly because patients in the
`MOH and CTTH were older, and the prevalence of
`hypertension is known to increase with age. In the
`statistical analysis however the difference in the
`prevalence of hypertension proved highly signifi-
`cant, both considering all the eight subgroups
`(P < 0.001) or only the four main subgroups
`(P < 0.001).
`(MA, MO, ETTH and CTTH)
`Merging MA with MO and ETTH with CTTH, to
`obtain a Ômigraine groupÕ and a Ôtension-type
`headache groupÕ, the difference in the prevalence
`of hypertension was again significant (P < 0.001)
`with hypertension being more frequent in tension-
`
`2
`
`2
`
`

`

`Hypertension in headache patients
`
`Table 1 Demographic characteristics of the different headache subtypes in the patient sample
`
`MOH (n ¼ 33) CH (n ¼ 60) CTTH (n ¼ 94)
`
`ETTH (n ¼ 105) MA (n ¼ 124) MO (n ¼ 718) Mixed (n ¼ 342) Other (n ¼ 10)
`
`Total (n ¼ 1486)
`
`Females
`Males
`Mean age (SD)
`
`30
`3
`47.9 (14.5)
`
`13
`47
`40.1 (11.8)
`
`64
`30
`40.8 (18.1)
`
`50
`55
`36.2 (18.7)
`
`90
`34
`32.5 (14.2)
`
`493
`225
`35.1 (14.1)
`
`263
`79
`36 (14.4)
`
`5
`5
`43.6 (15.7)
`
`1008
`478
`36.1 (14.9)
`
`MOH, medication-overuse headache; CH, cluster headache; CTTH, chronic tension-type headache; ETTH, episodic tension-type headache; MA, migraine with aura; MO,
`migraine without aura; Mixed, mixed headache (see text); Other, all other forms.
`
`Table 2 Actual and theoretical* prevalence of hypertension in patients with different headache subtypes
`
`MOH (n ¼ 33)
`
`CH (n ¼ 60)
`
`CTTH (n ¼ 94)
`
`ETTH (n ¼ 105) MA (n ¼ 124) MO (n ¼ 718) Mixed (n ¼ 342) Other (n ¼ 10)
`
`Total (n ¼ 1486)
`
`Actual
`Theoretical*
`
`20 (60.6)
`14 (42.4)
`
`21 (35)
`23 (38.3)
`
`52 (55.3)
`33 (35.1)
`
`33 (31.4)
`33 (31.4)
`
`21 (16.9)
`29 (23.4)
`
`165 (23)
`190 (26.5)
`
`97 (28.4)
`90 (26.3)
`
`7 (70.0)
`4 (40.0)
`
`416 (28)
`416 (28)
`
`Values in parentheses are in percentage. MOH, medication-overuse headache; CH, cluster headache; CTTH, chronic tension-type headache; ETTH, episodic tension-type
`headache; MA, migraine with aura; MO, migraine without aura; Mixed, mixed headache (see text); Other, all other forms.
`*Assuming absence of influence of headache subtype on hypertension, and after adjustment for age and gender.
`
`type headache than in migraine. Conversely, the
`differences within subtypes, i.e. between MA and
`MO on the one hand, and between ETTH and
`CTTH on the other, did not pass the significant test,
`although in the latter case the difference was greater.
`
`Discussion
`
`Although tension-type headache is more prevalent
`than migraine in the general population (20), MO
`was the more common diagnosis in our patients, in
`line with a similar study conducted in an other
`Headache Center (2). This may be due to the fact
`that only patients suffering from severe tension-
`type headache seek medical advise in specialized
`clinics. The number of patients with MOH (33 of
`1486 patients) was very low, compared to what is
`reported in the literature (20, 21), as many patients
`with MOH were hospitalized at our clinic, and
`their clinical recordings were not included in this
`study, that was conducted in an outpatient setting.
`The link between headache and hypertension has
`been addressed in relatively few studies, and is a
`highly controversial subject. Both conditions are
`extremely common in the general population, and
`their coexistence in an individual patient could
`therefore be merely coincidental.
`Comorbidity, e.g. between hypertension and
`migraine, or hypertension and tension-type head-
`ache, could be postulated only if the association
`between hypertension and some form of primary
`headache was observed systematically in the general
`population. Comorbidity, if present, could be due
`to different factors, e.g. a common physiopatho-
`logy, or the association with a particular genotype,
`although a preliminary study on genotyping for the
`
`complement C3F has apparently ruled out an
`association between migraine and hypertension
`ÔheadacheÕ
`(22). To further confound matters,
`could simply be a generic symptom of hypertension
`(and therefore a secondary headache), and in fact as
`early as in 1913 headache was indicated as the most
`common complaint in hypertensive patients (23),
`and recently an association between hypertension
`and morning headaches was evidenced (24), but in
`neither of these two studies it was possible to
`distinguish true migraine, or true tension-type
`headache, or a secondary headache due to hyper-
`tension, from a generic complaint of ÔheadacheÕ.
`Other studies did not show a positive association
`between headache and hypertension (25, 26) or
`suggested that headache could be a side effect of
`antihypertensive
`treatment
`(27–29). Probably
`reflecting uncertainty about this matter,
`in the
`latest classification of headache disorders (19),
`under the heading Ôsecondary headachesÕ,
`it is
`stated that Ômild or moderate hypertension does
`not appear to cause headache, and whether mod-
`erate hypertension predisposes to headache remains
`controversialÕ. We found a high prevalence of
`hypertension in patients with primary headaches,
`particularly in CTTH, CH and ETTH, and even
`higher in patients wit MOH. The prevalence of
`hypertension in our study, for all headache and age
`subgroups (data not shown), was higher than that
`observed in the general population (30). After age-
`and gender-adjustment, hypertension was found to
`be more common in tension-type headache than in
`migraine,
`suggesting
`a possible
`comorbidity
`between tension-type headache and hypertension.
`To our knowledge, this is the first report of such
`a finding. In another study on a sample of patients
`
`261
`
`3
`
`3
`
`

`

`Pietrini et al.
`
`observed at an Headache Center, Cirillo et al. (2)
`found a prevalence of hypertension comparable to
`our results for MO and MA, but not for tension-
`type headache, where a lower prevalence of
`hypertension was found. Another study still, once
`again at an Headache Center but on a small sample
`of patients, gave results in line with our findings for
`the prevalence of hypertension both in migraine
`and tension-type headache (3).
`Other studies have questioned the association
`between headache and hypertension (5–7), or have
`shown a higher prevalence of headache in subjects
`with lower blood pressure values (8). Interestingly,
`however, in one of these negative studies (8), a link
`between high diastolic blood pressure values and
`headache in men and migraine in women was
`found in one of the analyses, rendering the results
`of the study less clear-cut. Moreover, one study
`giving negative results (5) was based on the
`behaviour of ambulatory blood pressure deter-
`minations surrounding episodes of headache in
`hypertensive patients, and addressed therefore a
`somehow different problem. We suspect that the
`discrepancies in the results of these studies could be
`due to the substantial difference in the observed
`populations: two of the remaining three studies
`showing negative results were conducted in the
`general population (6, 8), and headache character-
`istics is subjects sampled from the general popula-
`tion could be different from those of patients
`coming to the observation of Headache Centers,
`who normally have more disabling symptoms. In
`short, the results of our study could be limited to
`patients with more severe forms of headache, in
`whom hypertension could cause a higher frequency
`and a greater severity of attacks. The association
`between chronic daily headache and hypertension
`has already been reported (12–16). Only large and
`accurately planned studies conducted in the general
`population could help to assess the possible exist-
`ence of comorbidity between hypertension and
`some forms of primary headache, and the preval-
`ence of secondary headache, due to hypertension.
`Patients enrolled in clinic-based study form a
`sample subject to the so-called Berkson’s bias (31),
`as patients with both hypertension and headache
`are more likely to come to the observation of
`Headache Centers (or other hospital-based clinics)
`than patients with headache only, or hypertension
`only, giving rise to a spurious association. Indeed,
`we tend to think that this is in fact the point, and
`that hypertension causes an exacerbation in the
`frequency and severity of attacks, probably in
`tension-type headache more than in migraine,
`urging patients to seek medical help in Headache
`Centers.
`Interestingly, we found a very high
`
`262
`
`prevalence of hypertension in patients with abuse
`of analgesics, and this seems to be only partially due
`to the demographic characteristics of this subgroup
`(Tables 1 and 2) so that the pharmacological effects
`of NSAIDs could be involved for patients taking
`these drugs, as the administration of some NSAIDs
`has been associated with an increase in blood
`pressure values (32, 33). An alternative explanation
`could again invoke hypertension causing an
`increase in the frequency and intensity of attacks,
`leading to overuse of analgesics.
`In conclusion, we found a high prevalence of
`hypertension in MOH and in different forms of
`primary headaches, and in patients with tension-
`type headache more than in patients with migraine,
`although these findings could be limited to patients
`coming to the observation of Headache Centers.
`This is not without therapeutic implications: in our
`experience, a good control of hypertension (and
`particularly of diastolic blood pressure values) is
`essential in order to alleviate or resolve headache
`symptoms both in migraine and tension-type
`headache. Well designed population-based studies
`would be needed to estimate the true prevalence of
`hypertension in primary headaches
`such as
`migraine,
`tension-type headache and CH, and
`also the prevalence of secondary headache, due to
`hypertension.
`
`References
`
`1. Franceschi M, Colombo B, Rossi P, Canal N. Headache in a
`population-based elderly cohort. An ancillary study to the
`Italian Longitudinal Study of aging (ILSA). Headache
`1997;37:79–82.
`2. Cirillo M, Stellato D, Lombardi C, De Santo NG, Covelli
`V. Headache and cardiovascular risk factors: positive
`association with hypertension. Headache 1999;39:409–16.
`3. Grebe HP, Nunes da Silva MJ, Diogo-Sousa L. Role of
`arterial hypertension in comorbidity of chronic headaches.
`Rev Neurol 2001;33:119–22.
`4. Rasmussen BK, Olesen J. Symptomatic and nonsympto-
`matic headaches in a general population. Neurology
`1992;42:1225–31.
`5. Gus M, Fuchs FD, Pimentel M, Rosa D, Melo AG, Moreira
`LB. Behaviour of ambulatory blood pressure surrounding
`episodes of headache in mildly hypertensive patients. Arch
`Intern Med 2001;161:252–5.
`6. Wiehe M, Costa Fuchs S, Moreira LB, Stoll Moraes R,
`Fuchs FD. Migraine is more frequent in individuals with
`optimal and normal blood pressure: a population-based
`study. J Hypertens 2002;20:1303–6.
`7. Fuchs FD, Gus M, Moreira LB, Moreira WD, Goncalves SC,
`Nunes G. Headache is not more frequent among patients
`with moderate to severe hypertension. J Hum Hypertens
`2003;17:787–90.
`8. Hagen K, Stovner LJ, Vatten L, Holmen J, Zwart JA, Bovim
`G. Blood pressure and risk of headache: a prospective
`study of 22685 adults in Norway. J Neurol Neurosurg
`Psychiatry 2002;72:463–6.
`
`4
`
`4
`
`

`

`9. Cooper WD, Glover J, Hormbrey JM, Kimeber GR. Head-
`ache and blood pressure: evidence of a close relationship.
`J Hum Hypertens 1989;3:41–4.
`10. Hansson L, Smith DHG, Reeves R, Lapuerta P. Headache
`in mild-to-moderate hypertension and its
`reduction
`by irbesartan therapy. Arch Intern Med 2000;160:
`1654–8.
`11. Hansson L, Zanchetti A, Carruthers SG et al.
`for the
`Hypertension Optimal Treatment (HOT) Study Group.
`Effects of intensive blood-pressure lowering and low-dose
`aspirin in patients with hypertension: principal results of
`the Hypertension Optimal Treatment (HOT) randomised
`trial. Lancet 1998;351:1755–62.
`12. Mathew NT, Stubits E, Nigam MR. Transformation of
`migraine into daily headache: analysis of factors. Head-
`ache 1982;22:66–8.
`13. Granella F, Farina S, Malferrari G, Manzoni GC. Drug
`abuse in chronic headache: a clinico-epidemiological study.
`Cephalalgia 1987;7:15–9.
`14. Micieli G, Piazza D, Sinforiani E et al. Antimigraine drugs
`in the management of daily chronic headaches: clinical
`profiles of responsive patients. Cephalalgia 1985;5(Suppl.
`2):219–24.
`15. Baldrati A, Bini L, D’Alessandro R et al. Analysis of
`outcome predictors of migraine towards chronicity. Cep-
`halalgia 1985;5(Suppl. 2):195–9.
`16. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB.
`Chronid daily headache: identification of factors associ-
`ated with induction and transformation. Headache
`2002;42:575–81.
`17. National Institute of Health. The Sixth Report of the Joint
`National Committee on Prevention, Detection, Evalua-
`tion, and Treatment of High Blood Pressure. National
`Institute of Health, NIH Publication no. 98-4080, 1997.
`18. Headache Classification Committee of the International
`Headache Society. Classification and diagnostic criteria for
`headache disorders, cranial neuralgias and facial pain.
`Cephalalgia 1988;8(Suppl. 7):1–96.
`19. Headache Classification Subcommittee of the International
`Headache Society. The International Classification of
`Headache Disorders.
`Cephalalgia
`2004;24(Suppl.
`1):1–151.
`20. Rassmussen BK, Jensen R, Scroll M, Olesen J. Epidemiology
`of headache in a general population – a prevalence study.
`J Clin Epidemiol 1991;44:1147–57.
`21. Mathew NT.
`Transformed migraine. Cephalalgia
`1993;13(Suppl. 12):78–83.
`22. Peroutka SJ, Price SC, Jones KW. The comorbid association
`of migraine with osteoarthritis and hypertension: comple-
`ment C3F and Berkson’s bias. Cephalalgia 1997;17:23–6.
`23. Janeway TC. A clinical study of hypertensive cardiovascu-
`lar disease. Arch Intern Med 1913;12:755–98.
`24. Ohayon MM. Prevalence and risk factors of morning
`headaches in the general population. Arch Intern Med
`2004;164:97–102.
`25. Stewart McDG. Headache and hypertension. Lancet
`1953;1:1261–6.
`26. Weiss NS. Relation of high blood pressure to headache,
`epistaxis and selected other symptoms. N Engl J Med
`1972;287:631–3.
`27. Brater DC. Benefits and risks of torasemide in congestive
`heart
`failure and essential hypertension. Drug Saf
`1996;14:104–20.
`28. Lee CR, Bryson HM. Lacidipine: a review of its pharmac-
`odynamic and pharmacokinetic properties and therapeutic
`potential
`in the
`treatment of hypertension. Drugs
`1994;48:274–96.
`
`Hypertension in headache patients
`
`29. Brogden RN, Wiseman LR. Moexipril: a review of its use in
`the management of
`essential hypertension. Drugs
`1998;55:845–60.
`30. Burt VL, Whelton P, Roccella EJ et al. Prevalence of
`hypertension in the US adult population. Results from the
`Third National Health and Nutrition Examination Survey,
`1998–91. Hypertension 1995;25:305–13.
`31. Berkson J. Limitations of the application of fourfold table
`analysis to hospital data. Biometrics 1946;2:47.
`32. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the
`effects of nonsteroidal anti-inflammatory drugs on blood
`pressure. Arch Intern Med 1993;153:477–84.
`33. Klassen D, Goodfriend TL, Schuna AA, Young DY, Peterson
`CA. Assessment of blood pressure during treatment with
`naproxen or ibuprofen in hypertensive patients treated
`with hydrochlorothiazide. J Clin Pharmacol 1993;33:
`971–8.
`
`Appendix
`
`The indirect standardization procedure with which we deter-
`mined the theoretical number of hypertensive patients by
`headache subtype is as follows. Table A1 gives the distribution
`by sex and age class of our patients in general and of those with
`hypertension. We can therefore calculate the proportions with
`hypertension in each cell.
`We now observe the sex and age distribution of patients
`with the various headache subtypes, and apply the proportions
`with hypertension obtained (column c in Table A1) to estimate
`the theoretical frequencies,
`i.e. the number of hypertensive
`patients we should expect in each case if age and sex had an
`
`Table A1 Demographic characteristics of the different headache subtypes in the
`patient sample
`
`(a) All patients
`
`(b) Hypertensive
`patients
`
`(c) % with
`hypertension
`
`Age class
`
`Females Males All
`
`Females Males All
`
`Females Males All
`
`0–17
`18–29
`30–39
`40–49
`50–59
`60–69
`70+
`All
`
`95
`256
`256
`187
`133
`63
`18
`1008
`
`80
`104
`133
`92
`38
`20
`11
`478
`
`175
`360
`389
`279
`171
`83
`29
`1486
`
`0
`27
`52
`53
`69
`45
`15
`261
`
`0
`24
`49
`37
`25
`10
`10
`155
`
`0
`51
`101
`90
`94
`55
`25
`416
`
`0.0
`10.5
`20.3
`28.3
`51.9
`71.4
`83.3
`25.9
`
`0.0
`23.1
`36.8
`40.2
`65.8
`50.0
`90.9
`32.4
`
`0.0
`14.2
`26.0
`32.3
`55.0
`66.3
`86.2
`28.0
`
`Table A2 Demographic characteristics of the different headache subtypes in the
`patient sample
`
`(a) Headache subtype: CTTH
`
`(b) Theoretical hypertensive
`
`Age class
`
`Females
`
`Males
`
`0–17
`18–29
`30–39
`40–49
`50–59
`60–69
`70+
`All
`
`5
`17
`9
`8
`10
`12
`3
`64
`
`4
`7
`6
`7
`2
`1
`3
`30
`
`All
`
`9
`24
`15
`15
`12
`13
`6
`94
`
`Females
`
`Males
`
`0
`1.8
`1.8
`2.3
`5.2
`8.6
`2.5
`22.1
`
`0
`1.6
`2.2
`2.8
`1.3
`0.5
`2.7
`11.2
`
`All
`
`0
`3.4
`4.0
`5.1
`6.5
`9.1
`5.2
`33.3
`
`263
`
`5
`
`5
`
`

`

`Pietrini et al.
`
`impact on hypertension, but the headache subtype under
`scrutiny had not. For instance, for the 94 patients with CTTH
`we find the data of Table A2, where the theoretical number of
`hypertensive patients of column (b) is obtained by multiplying
`the empirical frequencies of column (a) by the proportions of
`
`column (c) of Table A1. This gives about 33 expected
`hypertensive patients with CTTH and therefore about
`(94 ) 33¼) 61 non-hypertensive patients with CTTH. Repeat-
`ing the procedure by all headache subtypes gives the expected
`figures of Table 2 in the text.
`
`264
`
`6
`
`6
`
`

`

`ACTA
`NEUROLOGICA
`SCANDINAVICA
`
`www.bJackwellpublishing.com/ane
`
`Aim and scope
`
`Sconainavica
`The aim of Acta Neurologica
`representing
`of a high scientific quality
`is to publish manuscripts
`original clinical, diagnostic
`or experimental work in neuroscience.
`The scope is to act as an international
`forum
`for the dissemination
`of information
`advancing
`the science or practice of this subject area. Papers
`in English will
`be welcomed,
`especially those which bring new knowledge
`and observations
`from the application
`of therapies
`or
`techniques
`in the combating
`of a broad spectrum of neurological
`disease and neurodegenerative
`disorders.
`Relevant
`articles on the basic neurosciences will be published where they extend present
`understanding
`of such
`disorders.
`Priority will be given to review of topical
`subjects
`and timeliness will be included as "Short
`Papers
`requiring
`rapid publication
`because of their significance
`communications"
`not exceeding two printed pages, as will "Case histories"
`of sufficient general
`interest. Debate
`within the speciality is encouraged
`in the form of "Letters
`to the editor". All submitted manuscripts
`falling within
`the overall scope of the journal will be assessed by suitably qualified referees.
`
`in 2 volumes, one issue per month.
`
`for subscribers
`Information
`ACla Neucologica
`Scandmavtca
`is published
`Subscription
`prices for 2005 are:
`in the UK
`£560 (Rest of World). Customers
`Premium Institutional:
`£560 (Europe), US$941 (The Americas),
`should add VAT at 5%; customers
`in the ED should also add VAT at 5%, or provide
`a VAT registration
`number
`or evidence
`of entitlement
`to exemption.
`Customers
`in Canada
`should add 7% GST or provide
`evidence
`of entitlement
`to exception.
`The Premium institutional
`price includes
`online
`access
`to the current
`and all available
`previous
`year electronic
`issues. For other pricing options
`or more
`information
`about
`online
`access
`to Blackwell Publishing
`journals,
`including
`access
`information
`and terms
`and conditions,
`please visit
`www.blackwellpublishing.com/ane
`single issue price from
`the current
`at
`are available
`and recent volumes
`Back issues: Single issues from current
`issues may be obtained
`from Periodicals Service Company,
`11 Main
`Blackwell Publishing
`Journals.
`Earlier
`Street, Germantown, NY 12526, USA. Tel: + 15185374700,
`Fax: + 1 518 537 5899, Email: psc@backsets.com
`Aela Neurologica Scandtnavica (lSSN 0001-6314)
`is published monthly. US mailing agent: 03 Worldwide
`(US)
`Inc., 8701 Bellanca Ave., Los Angeles, CA 90045, USA.
`Periodical
`postage paid at Rahway, NJ and additional Mailing offices. Mailing to rest of world by Singapore
`to Acta Neurotogica Scandinavica, Blackwell Publishing
`Post Limited.
`Postmaster:
`Send all address changes
`Inc.,
`Journals Subscription Department,
`350 Main St., Malden, MA 02148-5020, USA.
`Journal Customer Services: For ordering information,
`claims and any enquiry concerning
`subscription
`please contact your nearest office:
`UK: Email: customerservices@oxon.blackweltpublishing.com;
`471775
`subscrip@bos.blackwellpublishing.com;Tel:
`USA: Email:
`USA); Fax: + 1 781 388 8232
`Fax: +61 383591120
`+61 383591100;
`Asia: Email:
`subs@blackwellpublishingasia.com;TeI:
`Production Editor: David Christie
`(email: ane@01\on.blackwellpubHshing.com).
`Advertising: Georgia Clarke (email: georgia.clarke@oxon.blackwellpublisbing.com)
`Commercial
`reprints: Tracy James
`(email:
`tracyjames@oxon.blackwellpublishing.com)
`forestry policy, and
`Blackwell Publishing's
`policy is to use permanent
`paper
`from mills that operate
`a sustainable
`which has been manufactured
`from pulp that
`is processed using acid-free and elementary
`chlorine-free
`practices.
`Furthermore,
`Blackwell Publishing
`ensures
`that
`the text paper and cover board used in all our journals
`has meL
`acceptable
`environmental
`accreditation
`standards.
`arising from the
`for errors or any consequences
`Disclaimer: The Publisher
`and Editors
`cannot be held responsible
`reflect
`those of
`use of information
`contained
`in this journal;
`the views and opinious
`expressed do not necessarily
`the Publisher
`and Editors,
`neither does the publication
`of advertisements
`constitute
`any endorsement
`by the
`Publisher
`and Editors
`of the products
`advertised
`stored or
`© 2005 Blackwell Munksgaard.
`All rights reserved. No part of this publication may be reproduced,
`holder.
`transmitted
`in any form or by any means without
`the prior permission
`in writing from the copyright
`libraries
`Authorization
`to photocopy
`items for internal
`and personal
`use is granted
`by the copyright
`holder
`for
`and other users registered with their
`local Reproduction
`Rights Organisation
`(RRO),
`e.g. Copyright Clearance
`Center
`(Ccq,
`222 Rosewood Drive, Danvers, MA 01923, USA (www.copyoght.coml.provided
`the appropriate
`fee is paid directly to the RRO.
`This consent does not extend to other kinds of copying such as copying
`for
`general distribution,
`for advertising
`or promotional
`purposes,
`for creating new collective works or
`for
`resale.
`Special
`requests
`should be addressed
`to Blackwell Publishing
`at: joumalsrights@oxon_blackwellpublishing.com.
`
`your journal
`
`Tel: +44 (0) 1865 778315; Fax: +44 (0) 1865
`
`+17813888206
`
`or
`
`I 800 835 6770 (Toll
`
`free in tbe
`
`ISSN 0001·6314 (Print)
`ISSN 1600-0404 (Online)
`Acta Neurologica
`Scandinavica
`(ISSN 0001-6314)
`Garsington
`Road, Oxford OX4 2XG, UK.
`in the developing world through
`Access to this journal
`is available
`free online within institutions
`initiative with the WHO. For
`information,
`visit www.healthinternetwork.org
`For submission instructions,
`subscription
`and all other
`information
`visit www.bJackwellpublishing.eom/ane.
`Printed in Singapore by Markono
`Print Media Pte Ltd.
`
`is published
`
`by Blackwell Publishing Ltd, PO Box 1354, 9600
`
`the HINARI
`
`Editor-in-chief
`
`MD. PhD
`Elinor Ben-Menachem,
`Department
`of Neurology
`5ahlgrenska University Hospital
`5-41345 Gothenburg,
`Sweden
`Tel: +46 31 3423100
`Fax: +46 31 3422467
`e-mail: acta@neuro.gu.se
`
`Associate editor
`
`Carsten Wikkels0, MD, PhD
`(Address details as for Eortor-in-cbiet.)
`
`Book review editor
`
`Professor Lars Forsgren
`Neurocentrum
`Norrlands University Hospital
`90185 Umea, Sweden
`e-mail:
`!ars.forsgren@neuro.umu.se
`
`Editorial Board
`
`Jens Astrup, Arhus
`Johan Aarli, Bergen
`AP. Aldenkamp, Heeze
`Oluf Andersen, Gothenburg
`V. Elving Anderson, Minneapolis
`S.M. Aquilonius, Uppsala
`Giuliano Avanzini, Milano
`Peter Boesiger, Zurich
`David Chadwick,
`liverpool
`Joyce Cramer. West Haven
`Marinos C. Delekes. Bethesda
`Mogens Dam, Arhus
`Mikael Elam, Gothenburg
`Peter Eriksson, Gothenburg
`Lars Forsgren, Urnes
`Albert Gjedde, Arhus
`Peter J. Goadsby, London
`W.A. Hauser, New York
`K.G. Henriksson,
`linkoping
`Joseph JankOVIC, Houston
`Kurt Jellinger, Vienna
`Barbre Johansson,
`Lund
`Amos Korczyn, Tel Aviv
`Marten Kyllerman, Gothenburg
`Bertil Lindblom, Gothenburg
`Michael A. Moskowitz,
`Boston
`Emilio Perruce. Pavia
`John D. Pickard

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket